https://orcid.org/0000-0002-2101-9398
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaohui Tan, Huandi Zhou, Liubing Hou, Haonan Li, Junling Liu, Yuehong Li & Xiaoying Xue. (2022) Expression and prognosis of GNG5 in lower-grade glioma using public database. All Life 15:1, pages 1101-1116.
Read now
Read now
Sudha Vijayan, Chitra Loganathan, Penislusshiyan Sakayanathan & Palvannan Thayumanavan. (2022) In silico and in vitro investigation of anticancer effect of newly synthesized nonivamide-s-allyl cysteine ester. Journal of Biomolecular Structure and Dynamics 40:22, pages 11511-11525.
Read now
Read now
Articles from other publishers (29)
Kyle L. Dunbar, Bruno Perlatti, Nicholas Liu, Amber Cornelius, Daniel Mummau, Yi-Ming Chiang, Lawrence Hon, Monika Nimavat, Jason Pallas, Sina Kordes, Ho Leung Ng & Colin J. B. Harvey. (2023) Resistance gene–guided genome mining reveals the roseopurpurins as inhibitors of cyclin-dependent kinases. Proceedings of the National Academy of Sciences 120:48.
Crossref
Crossref
Mohammed Alrouji, Lizy Sonia Benjamin, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, Saleh Salem Baeesa, Mohd Rehan, Moyad Shahwan, Anas Shamsi & Atiya Akhtar. (2023) Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies. Scientific Reports 13:1.
Crossref
Crossref
Alicia Milagros de Luna Aguilar, Javier David Benitez Fuentes, Justo Ortega Anselmi, Jennifer Olalla Inoa, Paloma Flores Navarro, Alfonso Lopez de Sá, Jesus Fuentes Antras, Cristina Rodríguez Rey, Aída Ortega Candil, Fernando Moreno Antón & Jose Ángel García Sáenz. (2023) Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study. Cancers 15:18, pages 4452.
Crossref
Crossref
Zhitao Hou, Xinyu Yang, Ling Jiang, Liying Song, Yang Li, Dongdong Li, Yanning Che, Xiuling Zhang, Zhongren Sun, Hongcai Shang & Jing Chen. (2023) Active components and molecular mechanisms of Sagacious Confucius’ Pillow Elixir to treat cognitive impairment based on systems pharmacology. Aging 15:14, pages 7278-7307.
Crossref
Crossref
Yulong Chong, Chunran Zhu, Wei Hu, Chengrong Jiang, Weibang Liang & Zongjing Zhu. (2022) miR-212-5p Suppresses Glioma Development via Targeting SUMO2. Biochemical Genetics 61:1, pages 35-47.
Crossref
Crossref
Aravinda Pai & Jayashree B.S.. (2022) Novel benzylidene benzofuranone analogues as potential anticancer agents: design, synthesis and in vitro evaluation based on CDK2 inhibition assays. 3 Biotech 12:10.
Crossref
Crossref
Mitul Srivastava, Lovika Mittal, Anita Kumari, Ashish Kumar Agrahari, Mrityunjay Singh, Rajani Mathur & Shailendra Asthana. (2022)
Characterizing (un)binding mechanism of
USP7
inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint
. Protein Science 31:9.
Crossref
Crossref
Ved Vrat Verma, Lalit Bhargava, Mohammad Sajid, Amit Kumar, Harpreet Singh & Mausumi Bharadwaj. (2022) Structure‐based study to identify alkaloids as promising cytochrome P450 (CYP1A1) inhibitors: An in silico approach using virtual screening, molecular dynamic simulations, and binding free energy calculation. Journal of Cellular Biochemistry 123:9, pages 1422-1439.
Crossref
Crossref
Hina Qayoom, Umar Mehraj, Shazia Sofi, Shariqa Aisha, Abdullah Almilaibary, Mustfa Alkhanani & Manzoor Ahmad Mir. (2022) Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Medical Oncology 39:10.
Crossref
Crossref
Fereshteh Noroozi Tiyoula, Hassan Aryapour & Mostafa Javaheri Moghadam. (2022) Comparative study of the unbinding process of some HTLV-1 protease inhibitors using unbiased molecular dynamics simulations. PLOS ONE 17:7, pages e0263200.
Crossref
Crossref
Rajib Hossain, Pranta Ray, Chandan Sarkar, Md. Shahazul Islam, Rasel Ahmed Khan, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam, William C. Cho, Miquel Martorell, Javad Sharifi-Rad, Monica Butnariu, Almagul Umbetova & Daniela Calina. (2022) Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study. BioMed Research International 2022, pages 1-10.
Crossref
Crossref
Guang-yao Chen, Xiao-yu Liu, Jing Luo, Xin-bo Yu, Yi Liu & Qing-wen Tao. (2022) Integrating Network Pharmacology and Experimental Validation to Explore the Key Mechanism of Gubitong Recipe in the Treatment of Osteoarthritis. Computational and Mathematical Methods in Medicine 2022, pages 1-25.
Crossref
Crossref
Vijay Kumar Bhardwaj & Rituraj Purohit. (2022) A lesson for the maestro of the replication fork: Targeting the protein‐binding interface of proliferating cell nuclear antigen for anticancer therapy. Journal of Cellular Biochemistry 123:6, pages 1091-1102.
Crossref
Crossref
Mina Zhang, Bo Lian, Rui Zhang, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, Yan Lin, Xuerui Wang, Qingquan Liu & Xiaolong Xu. (2022) Emodin Ameliorates Intestinal Dysfunction by Maintaining Intestinal Barrier Integrity and Modulating the Microbiota in Septic Mice. Mediators of Inflammation 2022, pages 1-16.
Crossref
Crossref
Somayye Taghvaei & Leila Saremi. (2022) Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease. PPAR Research 2022, pages 1-10.
Crossref
Crossref
Yiwen Xiao, Weizhong Liang, De Liu, Zhibin Zhang, Jun Chang & Du Zhu. (2022) Isolation and acetylcholinesterase inhibitory activity of asterric acid derivatives produced by Talaromyces aurantiacus FL15, an endophytic fungus from Huperzia serrata. 3 Biotech 12:3.
Crossref
Crossref
Aboubakr H. Abdelmonsef, Mohamed A. Abdelhakeem, Ahmed M. Mosallam, Hussain Temairk, Mohamed El‐Naggar, Hend Okasha & Huda R. M. Rashdan. (2021) A search for antiinflammatory therapies: Synthesis, in silico investigation of the mode of action, and in vitro analyses of new quinazolin‐2,4‐dione derivatives targeting phosphodiesterase‐4 enzyme. Journal of Heterocyclic Chemistry 59:3, pages 474-492.
Crossref
Crossref
Amar Ghosh, Anu Manhas & Prakash C. Jha. (2022) Computational studies to identify the common type‐I and type‐II inhibitors against the CDK8 enzyme. Journal of Cellular Biochemistry 123:3, pages 628-643.
Crossref
Crossref
Lu Wang, Wenxiang Zhu, Rui Sun, Jing Liu, Qihong Ma, Binbin Zhang & Yuanyuan Shi. (2022) Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Wen-Yu-Jin against Pulmonary Fibrosis in a Mouse Model. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-16.
Crossref
Crossref
Vijay kumar Bhardwaj, Pralay Das & Rituraj Purohit. (2022) Identification and comparison of plant-derived scaffolds as selective CDK5 inhibitors against standard molecules: Insights from umbrella sampling simulations. Journal of Molecular Liquids 348, pages 118015.
Crossref
Crossref
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Rituraj Purohit & Sanjay Kumar. (2022) In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. Journal of Traditional and Complementary Medicine 12:1, pages 35-43.
Crossref
Crossref
Jenniffer Cruz, Miguel Orlando Suárez-Barrera, Paola Rondón-Villarreal, Andrés Olarte-Diaz, Fanny Guzmán, Lydia Visser & Nohora Juliana Rueda-Forero. (2021) Computational study, synthesis and evaluation of active peptides derived from Parasporin-2 and spike protein from Alphacoronavirus against colorectal cancer cells. Bioscience Reports 41:12.
Crossref
Crossref
Christine Pho, Madison Frieler, Giri R. Akkaraju, Anton V. Naumov & Hana M. Dobrovolny. (2021) Using mathematical modeling to estimate time-independent cancer chemotherapy efficacy parameters. In Silico Pharmacology 10:1.
Crossref
Crossref
Rahul Singh, Vijay Kumar Bhardwaj, Pralay Das & Rituraj Purohit. (2021) New ecdysone receptor agonists: a computational approach for rational discovery of insecticides for crop protection. Molecular Systems Design & Engineering 6:11, pages 936-945.
Crossref
Crossref
Sachin Kumar, Vijay Kumar Bhardwaj, Anish Kaachra, Shweta Guleria, Arun Kumar, Rituraj Purohit & Sanjay Kumar. (2021) Site-directed mutagenesis (P61G) of copper, zinc superoxide dismutase enhances its kinetic properties and tolerance to inactivation by H2O2. Plant Physiology and Biochemistry 168, pages 221-229.
Crossref
Crossref
Sachin Kumar, Vijay Kumar Bhardwaj, Rahul Singh & Rituraj Purohit. (2021) Explicit-solvent molecular dynamics simulations revealed conformational regain and aggregation inhibition of I113T SOD1 by Himalayan bioactive molecules. Journal of Molecular Liquids 339, pages 116798.
Crossref
Crossref
Saleha Anwar, Shama Khan, Anas Shamsi, Farah Anjum, Alaa Shafie, Asimul Islam, Faizan Ahmad & Md. Imtaiyaz Hassan. (2021) Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. Journal of Cellular Biochemistry 122:10, pages 1445-1459.
Crossref
Crossref
Mahjerin Nasrin Reza, Nadim Ferdous, Md. Tabassum Hossain Emon, Md. Shariful Islam, A. K. M. Mohiuddin & Mohammad Uzzal Hossain. (2021) Pathogenic genetic variants from highly connected cancer susceptibility genes confer the loss of structural stability. Scientific Reports 11:1.
Crossref
Crossref
Ki Kwang Oh, Md. Adnan & Dong Ha Cho. (2021)
A network pharmacology analysis on drug‐like compounds from
Ganoderma lucidum
for alleviation of atherosclerosis
. Journal of Food Biochemistry 45:9.
Crossref
Crossref